Introduction {#sec1}
============

The communesin alkaloids are a family of nine polycyclic natural products, which possess notable biological activities and a range of interesting structural features ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}).^[@ref1]^ (−)-Communesin A (**2**) and B (**4**) were first isolated in 1993 by Numata and co-workers from an algal-derived *Penicillium* fungus and were found to exhibit moderate to potent cytotoxicity against cultured murine lymphocytic leukemia cells.^[@cit1a]^ In the years since, seven more communesin alkaloids C--I ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}) have been isolated and shown to possess insecticidal, antiproliferative, and vasculogenetic activities.^[@ref1]^ The core structures of these alkaloids feature seven contiguous rings, two aminal linkages, and up to six stereogenic centers, of which two are vicinal and quaternary (C3a/C3a′). This formidable structural complexity coupled with an array of important biological activity prompted research efforts directed toward their total chemical synthesis, culminating in inventive solutions for the preparation of racemic^[@ref2]^ and enantiomerically enriched^[@ref3]^ samples of communesin F (**1**). However, access to the more complex C10-epoxide-containing communesins remains challenging. Indeed, other than Zuo and Ma's total synthesis of (−)-communesin A (**2**) and B (**4**) in 2011,^[@ref4]^ there have been no reports describing the synthesis of epoxy-communesins **2**--**9**. Therefore, we sought to develop a unified and convergent approach to all members of the communesin family and related complex derivatives to enable their detailed study. Herein, we report the first biomimetic enantioselective total synthesis of all eight known epoxide-bearing communesin alkaloids, including the first total synthesis of communesins C--E, and G--I, a set of unnatural analogues, and their side-by-side anticancer profiling against five human cancer cell lines. In addition, we revise the reported structure of (−)-communesin I (**9**)^[@cit1f]^ to (−)-(3″*R*)-communesin I (**10**, [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}).

![Structures of the Communesin Alkaloids.](ja9b07397_0001){#fig1}

In 2016, we reported the first biomimetic enantioselective total synthesis of (−)-communesin F (**1**) inspired by a hypothetical biosynthesis involving the oxidative union of *Penicillium* fungal alkaloid (−)-aurantioclavine (**11**) and tryptamine (**12**, [Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}).^[@cit3b]^ We anticipated that the resulting C3a--C3a′ linked heterodimer **15** would undergo a dynamic reorganization to afford the key structural elements of the communesin core **16**. Fortuitously, Tang, Garg, and Houk disclosed landmark biosynthetic and computational studies^[@ref5]^ which were in full accord with our biosynthetic hypotheses. They demonstrated that alkaloids (−)-**11** and **12** were essential biosynthetic precursors and, further, they identified a *Penicillium* P450 monooxygenase enzyme (CnsC) responsible for both their oxidative union and selective conversion to heptacycle **16** in preference to isomeric heptacycle **17**.

![Biogenesis of the Communesin Alkaloids](ja9b07397_0002){#sch1}

Our biomimetic approach to alkaloid (−)-**1** was predicated on the late-stage diazene-directed assembly of two amine fragments to secure the key C3a--C3a′ linkage with complete stereochemical control.^[@cit3b]^ We then deployed the resulting heterodimeric structure as a surrogate for the hypothetical biosynthetic intermediate **15**, which enabled the examination of conditions for a guided biomimetic aminal reorganization to furnish the core of the communesin alkaloids to the exclusion of other possible constitutional isomers. From this penultimate intermediate, we were able to access (−)-communesin F (**1**) in only one additional step. The success of our strategy to alkaloid (−)-**1** prompted the development of a unified approach to access the challenging epoxy-communesin alkaloids **2*****--*****10** ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}) via a convergent synthesis while accommodating acid sensitive intermediates bearing the C10-epoxide.

Results and Discussion {#sec2}
======================

As depicted in our representative retrosynthetic analysis of (−)-communesin A (2, [Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}), we envisioned access to all C10-epoxy-communesins **2**--**9** via a late-stage biomimetic aminal reorganization of the intermediate epoxy-heterodimer **19** followed by N1′ acylation. Importantly, we anticipate this late-stage N1′-acylation will enable access to all members of this alkaloid class containing diverse N1′ substituents. Next, consistent with our diazene-directed strategy for complex fragment assembly,^[@cit3b],[@ref6]^ we projected that the critical C3a--C3a′ linkage in **19** could be assembled via photoextrustion of dinitrogen from unsymmetrical diazene **22** and recombination of the resulting radical fragments **20** and **21**. We expected to assemble diazene **22** from epoxide-bearing C3a-amino oxindole **23** and C3a′-sulfamate **24**. We envisioned an early stage epoxidation to permit the key biomimetic rearrangement and to fully exploit our versatile and convergent approach. This strategy provides maximally divergent access to all C10-epoxy-communesins **2**--**9** from a single advanced synthetic intermediate, heterodimer **19**.

![Retrosynthetic Analysis of (−)-Communesin A (**2**)](ja9b07397_0003){#sch2}

Our total synthesis of alkaloids **2**--**10** ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}) began with the preparation of oxindole **23** and sulfamate **24**, the key amine fragments required for the synthesis of complex diazene **22**. The application of our silver(I)-mediated substitution chemistry enabled rapid and scalable access to sulfamate (+)-**24** ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}). Electrophilic activation of readily available enantioenriched C3a′-bromocyclotryptamine (+)-**25**^[@cit3b],[@cit6d],[@ref7]^ with silver(I) trifluoromethanesulfonate in the presence of 2,6-difluorophenylsulfamate and 2,6-di-*tert*-butyl-4-methylpyridine (DTBMP) afforded the corresponding sulfamate ester (+)-**24** in 69% yield.

![Gram-Scale Synthesis of Sulfamate (+)-**24**\
Reagents and conditions: (a) AgOTf, 2,6-di-*tert*-butyl-4-methyl-pyridine, 2,6-difluorophenyl sulfamate, CH~2~Cl~2~, 23 °C.](ja9b07397_0004){#sch3}

Having secured an efficient gram-scale synthesis of cyclotryptamine (+)-**24**, we turned our attention to the preparation of amino azepane fragment **23** which contains the key (C10*R*)-configured epoxide, a critical structural feature found in communesins **2**--**10**. Our initial efforts directed toward the synthesis of this intermediate and related derivatives revealed a *pronounced* acid-sensitivity of the C10-epoxide, which stems from facile intramolecular opening of the protonated epoxide with the *N*1-carbamate to form stable oxazolidinone products.^[@ref8]^ This precluded the use of Ellman's *tert*-butanesulfinamide chiral auxiliary,^[@ref9]^ which we previously employed en route to (−)-communesin F (**1**).^[@cit3b]^ Specifically, epoxidation of intermediates containing Ellman's auxiliary (i.e., the *tert*-butanesulfinamide variant of **32**) resulted in rapid concomitant oxidation of the sulfinamide to the corresponding *tert*-butanesulfonamide (Bus), which requires strong Bronsted acids, such as trifluoromethanesulfonic acid, to remove.^[@ref10]^ This unforeseen incompatibility prompted our design of 2-(trimethylsilyl)ethane sulfinamide (**26**), a new sulfinamide auxiliary whose oxidation product, 2-(trimethylsilyl)ethane sulfonamide (SES), can be removed under nonacidic and nonreducing conditions,^[@ref11]^ an essential requirement for the preservation of the sensitive C10-epoxide ([Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}).

![Synthesis of Epoxide (−)-**33** and Determination of Relative Stereochemistry at C10\
Reagents and conditions: (a) *N*-methyl-4-bromoisatin, Ti(OEt)~4~, CH~2~Cl~2~, 23 °C; (b) allylMgBr, MgBr~2~, CH~2~Cl~2~, −78 °C, \> 99:1 dr; (c) O~3~, MeOH, −78 °C; NaBH~4~, −78 °C → 23 °C; (d) *o*-NsNHCbz, DIAD, PPh~3~, THF, 50 °C; PhSH, Cs~2~CO~3~, 50 °C; (e) 1,1-dimethylallyl alcohol, Pd(OAc)~2~, Ag~2~CO~3~, DMF--H~2~O, 90 °C; (f) Ca(OTf)~2~, MeCN, 80 °C; (g) 1,1,1-trifluoroacetone, 30% aq. H~2~O~2~, K~2~CO~3~, EDTA, MeCN−H~2~O, 0 °C; (h) H~2~, Pd(OH)~2~/C, EtOH, 23 °C.](ja9b07397_0005){#sch4}

Multigram quantities of enantiopure (*S*)-sulfinamide (−)-**26** were prepared using readily available (−)-diacetone-[d]{.smallcaps}-glucose^[@ref12]^ as a chiral controller.^[@ref13]^ Condensation of the new chiral auxiliary (−)-**26** with *N*-methyl-4-bromoisatin in the presence of titanium(IV) ethoxide^[@cit3b],[@ref9]^ then afforded the corresponding sulfinyl imine (+)-**27** in 80% yield. Subsequent allylation with allylmagnesium bromide afforded the corresponding addition product (+)-**28** in 74% yield as a single diastereomer on a multigram scale after flash column chromatography. We were pleased to discover that the inherent diastereoselectivity imparted by this new auxiliary (84:16 dr) was remarkably similar to that observed with Ellman's *tert*-butanesulfinamide (87:13 dr) under identical reaction conditions,^[@cit3b],[@ref9]^ thereby validating the broader utility of sulfinamide (−)-**26** in stereoselective synthesis.

Ozonolysis of alkene (+)-**28** followed by in situ ozonide reduction with sodium borohydride furnished primary alcohol (+)-**29** in 85% yield. Mitsunobu displacement of the alcohol with *N*-carbobenzoxy-2-nitrobenzenesulfonamide (*o*-NsNHCbz) and in situ desulfonylation then afforded benzyl carbamate (+)-**30** in 76% overall yield. A palladium-catalyzed Mizoroki--Heck reaction with 1,1-dimethylallyl alcohol and silver(I) carbonate as the base then proceeded to furnish allylic alcohol (−)-**31** in 92% yield.^[@ref14]^ Unexpectedly, subjecting (−)-**31** to our previously employed palladium-catalyzed allylic amination conditions (PdCl~2~MeCN~2~, MeCN, 80 °C)^[@cit3b],[@ref15]^ resulted in complex mixtures containing only trace amounts of azepane (−)-**32**. The major side products were derived from sulfinamide epimerization and desulfinylation. We hypothesize that the transiently generated hydrochloric acid necessary for catalyst turnover^[@ref16]^ resulted in sulfinamide cleavage and release of the free amine and the corresponding sulfinyl chloride, which is expected to be configurationally unstable.^[@ref17]^ Recombination of the amine and the racemized sulfinyl chloride would then afford the observed diastereomeric sulfinamide. After extensive experimentation, we discovered that calcium(II) trifluoromethanesulfonate and related Lewis acids^[@ref18]^ could promote a highly efficient allylic amination without concomitant sulfinamide degradation. Indeed, under optimal conditions, gram scale synthesis of azepane (−)-**32** was achieved in 90% yield.

We then focused on the introduction of the critical C10-epoxide. We were pleased to discover that mild, efficient, and stereoselective epoxidation of this key intermediate could be achieved using in situ generated methyl(trifluoromethyl)-dioxirane (TFDO).^[@ref19],[@ref20]^ Exposure of an acetonitrile solution of (−)-**32** to aqueous potassium carbonate and aqueous hydrogen peroxide in the presence of 1,1,1-trifluoroacetone at 0 °C furnished the desired (C10*R*)-configured epoxide (−)-**33** in 81% yield in addition to the (C10*S*)-configured epoxide (−)-**34** in 8% yield, coupled with concomitant and planned oxidation of the alkane sulfinamide to the corresponding 2-(trimethylsilyl)ethane sulfonamide (SES).^[@ref21]^

The relative configuration at C10 of these epimeric epoxides was determined by nuclear Overhauser effect analysis on free amines (−)-**35** and (−)-**36** after hydrogenolytic removal of the benzyl carbamates ([Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}). According to Murata's *J*~H--H~-based method^[@ref22]^ as employed by Proksch,^[@cit1b]^ Christophersen,^[@cit1e]^ and Chen^[@cit1f]^ for communesins **4**--**9**, the large coupling constant between C9H and C10H (*J* ≈ 9.0 Hz) in both epoxides (−)-**35** and (−)-**36** indicates an approximately 180° dihedral angle between C9H and C10H, affording two possible diastereomeric *anti* configurations. In the case of epoxide (−)-**35**, the NOE enhancement observed at C5H when irradiating the geminal methyl groups is consistent with a *syn* orientation between the epoxide oxygen and N1 as depicted in the Newman projection in [Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"} and the (*R*)-configuration at C10. Conversely, the NOE enhancements observed at C2H in epoxide (−)-**36** when irradiating the geminal methyl groups suggests an *anti* orientation between the epoxide oxygen and N1 and thus the (*S*)-configuration at C10. Indeed, this assignment of epoxide (−)-**36** was later unambiguously confirmed by single-crystal X-ray diffraction.^[@ref13]^

With a stereoselective synthesis of epoxide (−)-**33** in hand, we moved to investigate C8a reduction and unveiling of the C3a amine as a prelude to our planned diazene synthesis. We initially targeted the introduction of a C8a-nitrile, which we have shown to be an ideal trigger for late-stage C8a-iminiun ion formation while providing adequate stability during the fragment assembly steps ([Scheme [5](#sch5){ref-type="scheme"}](#sch5){ref-type="scheme"}).^[@cit3b]^ To this end, partial reduction of oxindole (−)-**33** with lithium borohydride afforded the corresponding C8a-hemiaminal as a mixture of diastereomers. Treatment of the crude hemiaminal with trimethylsilyl cyanide in wet hexafluoroisopropanol (HFIP) afforded aminonitrile (+)-**37** in 57% yield.^[@ref13],[@ref23]^ Fluoride-mediated C3a-N desulfonylation with tris(dimethylamino)sulfonium difluorotrimethylsilicate (TASF)^[@ref24]^ in anhydrous *N*,*N*-dimethylformamide (DMF) at 100 °C provided benzylic amine (+)-**38** in 39% yield, with the C8a-epimer and the C8a-cyanoindole elimination product comprising the remainder of the mass balance. Attempts to attenuate the basicity of the reagent by the addition of water or other acidic additives proved unsuccessful in reducing the propensity of the substrate to undergo elimination or epimerization. To circumvent problematic side reactions, we opted to desulfonylate oxindole (−)-**33** directly and investigate C8a reduction after the fragment assembly. Indeed, treatment of sulfonamide (−)-**33** with TASF in wet DMF at 100 °C provided gram-scale access to amino-oxindole (−)-**23** in 69% yield.

![Synthesis of Amine Fragments (+)-**38** and (−)-**23**\
Reagents and conditions: (a) (i) LiBH~4~, MeOH, THF, 23 °C; (ii) TMSCN, H~2~O, HFIP, 0 °C → 23 °C. (b) TASF, DMF, 100 °C. (c) TASF, H~2~O, DMF, 100 °C.](ja9b07397_0006){#sch5}

With both critical amine fragments in hand, we then moved to explore their union and the introduction of the key C3a--C3a′ linkage. Simply stirring a tetrahydrofuran solution of amine (−)-**23** and sulfamate (+)-**24** in the presence of 4-(*N*,*N*-dimethylamino)pyridine (DMAP) afforded oxindole sulfamide (−)-**39** in 84% yield on a gram scale ([Scheme [6](#sch6){ref-type="scheme"}](#sch6){ref-type="scheme"}). Partial reduction of the oxindole with excess lithium borohydride and treatment of the resulting hemiaminal with trimethylsilyl cyanide in wet^[@ref25]^ hexafluoroisopropanol then afforded aminonitrile sulfamide (+)-**40** as a single diastereomer in 84% overall yield on a gram scale. Fortuitously, formation of the C8a-nitrile after fragment assembly proved to be much more efficient and diastereoselective, likely due to the steric bulk of the cyclotryptamine moiety that more effectively shields the bottom face of the C8a-iminium.

![Directed Synthesis of Heterodimer (+)-**19** via Diazene-Directed Fragment Assembly\
Reagents and conditions: (a) DMAP, THF, 23 °C. (b) (i) LiBH~4~, MeOH, THF, 23 °C; (ii) TMSCN, H~2~O, HFIP, 0 → 23 °C. (c) polystyrene--2-*tert*-butylimino-2-diethylamino-1,3-dimethylper-hydro-1,3,2-diazaphosphorine, *N*-chloro-*N*-methylbenzamide, MeOH, 23 °C. (d) *h*ν (350 nm), 25 °C. (e) H~2~, Pd(OH)~2~/C, EtOH, 23 °C.](ja9b07397_0007){#sch6}

Exposure of (+)-**40** to *N*-chloro-*N*-methylbenzamide in the presence of polystyrene-bound 2-*tert*-butylimino-2-diethylamino-1,3-dimethylperhydro-1,3,2-diazaphosphorine (BEMP) in methanol then afforded sensitive diazene **22** in 45% yield, without competitive oxidation of the electron-rich arene.^[@cit3b]^ Photoexcitation and expulsion of dinitrogen from a thin film of diazene **22** afforded the C3a--C3a′ linked heterodimer (+)-**41** in 50% yield as a single diastereomer via a completely stereoselective combination of the radical fragments **20** and **21** ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}).^[@ref26]^

Hydrogenolysis of the benzyl carbamates then furnished heterodimeric diamine (+)-**19** in 77% yield, setting the stage for our key biomimetic aminal reorganization. Consistent with the design principles underpinning our synthetic strategy, the position of the electron withdrawing group on the cyclotryptamine moiety enables selective cleavage of either aminal linkage, thereby controlling the regiochemical outcome of the rearrangement (vide infra). The N8′-sulfonamide of diamine (+)-**19** was expected to guide the cleavage of the C8a′--N8′ bond under basic conditions, leading to the heptacyclic core of the communesin alkaloids after formation of the C8a--N8′ and C8a′--N1 aminals ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}).

With the critical intermediate heterodimer (+)-**19** in hand, we turned our attention to the preparation of all known epoxide-containing members of the communesin family, beginning with *N*1′-acetyl communesins (−)-**2** and (−)-**3**, respectively. Importantly, we observed that a clean and complete rearrangement to the epoxide-appended communesin core could be achieved by exposing heterodimer (+)-**19** to ethanolic lithium *tert-*butoxide at 60 °C ([Scheme [7](#sch7){ref-type="scheme"}](#sch7){ref-type="scheme"}).^[@ref27]^ In situ neutralization of excess alkoxide with pyridinium *p*-toluenesulfonate (PPTS) followed by acetylation of the resulting sensitive heptacycle with acetic anhydride then furnished communesin derivative (−)-**42** in 82% yield. Analysis of the advanced intermediate (−)-**42** by single-crystal X-ray diffraction unambiguously confirms the stereochemical configuration of the C10-epoxide and provided *the first solid-state structure of the full polycyclic topology of the communesin alkaloids*.^[@ref13]^ The structure of intermediate (−)-**42** illustrates the compressed pyramidal N1-amine,^[@ref28]^ the preferred orientation of the N1′-acetyl group, and the positioning of the N8′-sulfonyl group, a substitution critical to the enhanced anticancer activity observed of new communesin derivatives (vide infra). Treatment of (−)-*N*8′-SES-communesin A (**42**) with TASF in degassed^[@ref29]^ DMF provided (−)-communesin A (**2**) in 77% yield. All ^1^H and ^13^C NMR data as well as optical rotation (observed \[α\]~D~^24^ = −165 (*c* = 0.39, CHCl~3~); lit: \[α\]~D~^22^ = −58 (*c* = 0.14, CHCl~3~),^[@cit1a]^ \[α\]~D~^20^ = −174 (*c* = 1.34, CHCl~3~),^[@cit1c]^ \[α\]~D~^30^ = −163.5 (*c* = 0.14, CHCl~3~)^[@ref4]^) for synthetic alkaloid (−)-**2** were consistent with literature values.

![Synthesis of All Known Epoxide-Bearing Communesins and Stereochemical Revision of (−)-Communesin I (**10**)\
Reagents and Conditions: (a) *t*-BuOLi, EtOH 60 °C; PPTS, Ac~2~O, 23 °C, 82%. (b) *t*-BuOLi, EtOH, 60 °C; PPTS, sorbic anhydride, 23 °C, 82%. (c) *t*-BuOLi, EtOH, 60 °C; PPTS, propionic anhydride, 23 °C, 86% (d) *t*-BuOLi, EtOH, 60 °C; PPTS, butyric anhydride, 23 °C, 84%. (e) *t*-BuOLi, EtOH, 60 °C; PPTS, (+)-**49**, 23 °C, 84%. (f) *t*-BuOLi, EtOH, 60 °C; PPTS, (+)-**51**, 23 °C, 48%. (g) pyridinium dichromate (PDC), K~2~CO~3~, 1,2-dichloroethane, 60 °C. (h) TASF, DMF, 23 °C. (i) (*i*) KOH, H~2~O--DMSO, 23 °C; (*ii*) TASF, DMF, 45 °C. (j) (*i*) KOH, H~2~O--DMSO, 23 °C; (*ii*) TASF, DMF, 23 °C. In the ORTEP representations of sulfonamide (−)-**42** and (−)-**45**, the thermal ellipsoids are drawn at 30% probability.](ja9b07397_0008){#sch7}

Oxidation of (−)-*N*8′-SES-communesin A (**42**) with pyridinium dichromate (PDC, 10 equiv)^[@cit2d],[@ref30]^ and potassium carbonate (40 equiv) in 1,2-dichloroethane at 60 °C provided the corresponding *N*8-formyl derivative (−)-**43** in 78% yield. Removal of the N8′-sulfonyl group from intermediate (−)-**43** resulted in (+)-*N*8-formyl communesin E (**44**) in 82% yield. Interestingly, this communesin derivative has not yet been isolated in nature to date, which is notable given that natural samples of (+)-communesin D (**6**), the closely related *N1*′-sorbyl derivative, have been repeatedly and independently isolated.^[@cit1b],[@cit1c]^ Alternatively, mild hydrolysis of formamide (−)-**43** with potassium hydroxide in wet dimethyl sulfoxide (DMSO) followed by desulfonylation afforded the first synthesis of (−)-communesin E (**3**) in 81% yield. All spectral data and optical rotation (observed \[α\]~D~^23^ = −191 (*c* = 0.31, CHCl~3~); lit: \[α\]~D~^20^ = −156 (*c* = 0.11, CHCl~3~)^[@cit1c]^) for alkaloid (−)-**3** were in agreement with the isolation report.

We next focused on the synthesis of N1′-sorbyl alkaloids (−)-communesins B--D (**4**--**6**, respectively). Treatment of heterodimeric diamine (+)-**19** with the aminal rearrangement conditions described above followed by acylation with sorbic anhydride afforded (−)-*N*8′-SES-communesin B (**45**) in 82% yield. Mild N8′-desulfonylation with TASF then afforded (−)-communesin B (**4**) in 86% yield, whose spectroscopic data as well as optical rotation (observed \[α\]~D~^23^ = −64 (*c* = 0.46, CHCl~3~); lit: \[α\]~D~^22^ = +8.7 (*c* = 0.23, CHCl~3~),^[@cit1a]^ \[α\]~D~ = −58 (*c* = 0.10, MeOH),^[@cit1b]^ \[α\]~D~^20^ = −74.9 (*c* = 1.50, CHCl~3~),^[@cit1c]^ \[α\]~D~^30^ = −51.3 (*c* = 0.30, CHCl~3~)^[@ref4]^) were consistent with previously reported values, with the exception of the anomalous positive value described in the first isolation report.^[@cit1a],[@ref31]^ Oxidation of advanced intermediate (−)-**45** with PDC provided the sensitive *N*8-formamide (+)-**46** in 66% yield which was then desulfonylated to provide the first synthesis of (+)-communesin D (**6**) in 83% yield. All ^1^H and ^13^C data as well as optical rotation (observed \[α\]~D~^23^ = +151 (*c* = 0.23, CHCl~3~); lit: \[α\]~D~^20^ = +150 (*c* = 0.14, CHCl~3~)^[@cit1c]^) of (+)-**6** were fully consistent with literature values. To complete the synthesis of all known N1′-sorbyl communesin derivatives, deformylation of the N8-formamide (+)-**46** followed by desulfonylation of the resulting crude amine produced (−)-communesin C (**5**) in 64% yield. The spectral data and optical rotation of alkaloid (−)-**5** (observed \[α\]~D~^23^ = −108 (*c* = 0.28, MeOH); lit: \[α\]~D~ = −30 (*c* = 0.038, MeOH)^[@cit1b]^) were in agreement with literature values. Importantly, analysis of the common precursor (−)-**45** by single-crystal X-ray diffraction unambiguously confirms the relative and absolute stereochemical configuration of all known *N*1′-sorbyl communesin alkaloids (−)-**4**, (−)-**5**, and (+)-**6** for the first time.

We next proceeded with the first total synthesis of (−)-communesin G (**7**) and H (**8**). Rearrangement of key intermediate (+)-**19** under the standard conditions followed by acylation with propionic anhydride efficiently furnished (−)-*N*8′-SES-communesin G (**47**) in 86% yield. Subsequent desulfonylation with TASF then afforded (−)-communesin G (**7**) in 74% yield, with spectral data and optical rotation (observed \[α\]~D~^23^ = −163 (*c* = 0.20, MeOH); lit: \[α\]~D~^25^ = −157 (*c* = 0.021, MeOH)^[@cit1e]^) fully consistent with those reported in the isolation report. Similarly, rearrangement of heterodimer (+)-**19**, acylation with butyric anhydride, and desulfonylation of the intermediate heptacycle (−)-**48** efficiently furnished (−)-communesin H (**8**) in 76% overall yield, with all spectral data and optical rotation (observed \[α\]~D~^23^ = −168 (*c* = 0.38, MeOH); lit: \[α\]~D~^25^ = −167 (*c* = 0.024, MeOH)^[@cit1e]^) identical to those available from isolation reports.

Finally, we turned our attention to the preparation of the reported structure of (−)-communesin I (**9**), the most recently isolated member of the communesin family. In order to introduce the (3″*S*)-hydroxy amide at N1′, we opted to use aldol addition product (+)-**49** as the acyl donor^[@ref13]^ after the key aminal reorganization. Rearrangement of heterodimer (+)-**19** followed by acylation of the resulting communesin core with excess aldol adduct (+)-**49** furnished amide (−)-**50** in 84% yield. Desulfonylation with TASF then afforded (−)-(3″*S*)-communesin I (**9**) in 86% yield, which enabled careful analysis of all spectral data and conclusive comparisons with the isolation data originally reported by Fan and co-workers^[@cit1f]^ for natural (−)-communesin I. The ^1^H and ^13^C NMR signals associated with the core of the alkaloid were in good agreement with the isolation report, however key ^1^H and ^13^C signals on the acyl chain deviated notably from the expected values. Specifically, the ^13^C NMR chemical shifts of C2″ (41.1^13^ vs 42.1^[@cit1f]^ ppm), C3″ (68.1^13^ vs 69.0^[@cit1f]^ ppm), and C4″ (38.8^13^ vs 39.5^[@cit1f]^ ppm) were found to be the most divergent.

In light of these data, we hypothesized that the stereochemical configuration at C3″ had been incorrectly assigned in the isolation report. Given the ease with which the diastereomeric aldol addition product (+)-**51** could be prepared, we opted to synthesize the corresponding (3″*R*) derivative (**10**) to test our hypothesis. Reorganization of key intermediate (+)-**19** followed by acylation with aldol addition product (+)-**51** furnished (3″*R*) derivative (−)-**52** in 48% yield, which upon N8′-desulfonylation afforded (−)-(3″*R*)-communesin I (**10**) in 78% yield. Importantly, all ^1^H and ^13^C NMR data of this alkaloid were in excellent agreement with those reported in Fan's isolation report^[@cit1f]^ of (−)-communesin I. The optical rotation was also consistent with the reported data, albeit our synthetic sample had a higher value (observed \[α\]~D~^23^ = −137 (*c* = 0.22, MeOH); lit: \[α\]~D~^20^ = −59 (*c* = 0.1, MeOH)^[@cit1f]^). As a result, we herein reassign the stereochemical configuration at C3″ of this new communesin alkaloid from (*S*) to (*R*). This important finding validates the importance of our strategic late-stage N1′ acylation, which enables the rapid diversification and functional derivatization of the communesin core.

To demonstrate the versatility of our highly convergent synthetic approach to all communesin alkaloids and related derivatives, we applied our synthetic strategy to prepare a constitutional isomer of the communesin skeleton, namely the *iso*-communesin^[@cit5b]^ core **17** ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}). We anticipated that this unnatural polycyclic topology would be accessible via an analogous aminal reorganization of a C3a--C3a′ linked heterodimer containing a cyclotryptamine fragment with an inverted N1′/N8′ substitution pattern. Treatment of this hypothetical substrate with the same basic conditions required to reorganize (+)-**19** should result in the selective cleavage of the C8a′--N1′ aminal, thereby resulting in the elements of the *iso*-communesin core after formation of the C8a--N1′ and C8a′--N1 aminal linkages. As depicted in [Scheme [8](#sch8){ref-type="scheme"}](#sch8){ref-type="scheme"}, fragment assembly of aminonitrile (+)-**38**^[@ref32]^ and the appropriately substituted C3a′-sulfamate (+)-**53**^[@ref13]^ afforded sulfamide (+)-**54** in 75% yield. Oxidation of (+)-**54** under the same conditions employed for sulfamide (+)-**40** afforded the sensitive diazene **55** in 57% yield. Photochemical irradiation of the diazene as a neat thin film at 350 nm then furnished the C3a--C3a′ fused heterodimer (+)-**56** in 53% yield. Hydrogenolysis of heterodimer (+)-**56** resulted in formation of the anticipated heterodimeric diamine **57** along with the partially rearranged compound **58** (**57**:**58**, 3:1). Notably, when a pure sample of diamine **57** was treated with lithium *tert*-butoxide (10 equiv) in methanol-*d*~4~ at 23 °C, rapid and complete conversion to **58** was observed by ^1^H NMR analysis. Evidently, the lower p*K*~a~ of indoline N8′H in heterodimer **57** relative to pyrrolidine N1′H in (+)-**19** enables cyclotryptamine-aminal opening even under the hydrogenolysis reaction conditions. Treatment of the crude hydrogenolysis product mixture of **57** and **58** with lithium *tert*-butoxide in ethanol at 60 °C resulted in clean conversion to *iso*-communesin derivative (+)-**59** in 46% overall yield from (+)-**56**. The structural assignment of the unnatural polycyclic topology of alkaloid (+)-**59** is supported by key HMBC data including the observed correlations C8aH--C2′ and C8a′H--C9 that conclusively establish the presence of the C8a--N1′ and C8a′--N1 aminals, respectively. The successful implementation of our synthetic strategy for the preparation of *iso-*communesin (+)-**59** further highlights the generality of our guided heterodimer rearrangement utilized in our syntheses described above.

![Guided Rearrangement to an Unnatural Communesin Related Topology\
Reagents and conditions: (a) DMAP, THF, 23 °C; (b) polystyrene--BEMP, *N*-chloro-*N*-methylbenzamide, MeOH, 23 °C; (c) *h*ν (350 nm), 25 °C; (d) (*i*) H~2~, Pd(OH)~2~/C, EtOH, 23 °C; (*ii*) *t*-BuOLi, EtOH, 60 °C.](ja9b07397_0009){#sch8}

With samples of all known communesin alkaloids and a selection of unnatural derivatives in hand, we set out to probe the anticancer activity for this entire class of natural products. While previous isolation reports have evaluated the activity of selected natural communesins, no comprehensive comparison of the entire class of alkaloids across multiple cell lines has been performed.^[@ref1]^ To this end, our synthetic samples of all nine naturally occurring communesins, a selection of seven complex intermediates from our synthetic campaign, and the *N*8′-sulfonylated *iso*-communesin (+)-**59** were examined for cytotoxicity against human lung carcinoma (A549), prostate carcinoma (DU 145), colorectal carcinoma (HCT 116), cervical adenocarcinoma (HeLa), and breast adenocarcinoma (MCF7) cell lines.^[@ref13]^ As depicted in [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, (−)-communesin B (**4**) exhibited the highest potency of all the natural alkaloids tested across all cell lines, which is consistent with leukemia-focused assays performed in early isolation reports.^[@cit1a],[@cit1b]^ The cytotoxicity of the natural products in our assays against adherent cell lines representing solid tumors is slightly less than those performed against the leukemia cell lines. This observation is not surprising given that it has been previously observed in large scale cell line profiling experiments that cell lines grown in suspension, such as leukemia and lymphoma, can be generally more sensitive to cytotoxic compounds relative to adherent cell lines.^[@ref33]^ The next most active natural alkaloid, (−)-communesin C (**5**), exhibited an approximately 2-fold decrease in potency in our assays, whereas alkaloids (−)-**2**, (−)-**3**, (−)-**7**, (−)-**9**, and (+)-**43** were principally inactive across the cell lines examined.

###### Assessment of All Known Communesin Alkaloids and a Selection of Unnatural Derivatives for Cytotoxicity Against Five Human Carcinoma Cell Lines.[a](#t1fn1){ref-type="table-fn"}

![](ja9b07397_0010){#GRAPHIC-d7e1855-autogenerated}

Cytotoxicity IC~50~ values (in μM) after 72 h of compound treatment as determined by Cell Titer-Glo (Promega) which measures ATP levels as a surrogate for cell viability. Error is standard deviation of the mean, *n* ≥ 2; IC~50~ = half maximal inhibitory concentration; Human Carcinoma Cell Lines: Lung (A549), Prostate (DU 145), Colorectal (HCT 116), Cervical (HeLa), and Breast (MCF7).

Interestingly, advanced synthetic intermediates that contain an *N*8′-SES substituent generally exhibited a dramatic increase in potency relative to the N8′ unsubstituted natural products ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}). For example, *N*8′-SES-communesin G, (−)-**47**, was found to exhibit an *approximately 10-fold increase in potency* relative to (−)-communesin G (**7**). This increase in activity was found to hold irrespective of N8 substitution (e.g., (+)-**46** vs (+)-**6**) or N1′ substitution (e.g., (−)-**45** vs (−)-**4**). In this preliminary structure--activity relationship study, we also noted that the N8 substituent exerts a small but measurable influence on potency. For example, a two- to three-fold decrease in activity was observed moving from *N*8-methyl alkaloid (−)-**4** to either *N*8-H alkaloid (−)-**5** or *N*8-formyl alkaloid (+)-**6**. Additionally, we observed a general correlation between the size of the N1′ substituent and the potency of the compound. This is particularly evident in the natural series, where the activity generally follows the trend *N*1′-sorbyl \> pentan-3*R*-ol \> butyryl \> propionyl \> acetyl. As noted with the N8 substituent, the *N*8′-SES derivatives also followed the same general trend, but they were less sensitive to variation at this position. Lastly, the *iso*-communesin derivative (+)-**59** exhibited inferior activity to all N8′-SES communesin derivatives tested as well as a number of more modestly active N8′-unsubstituted natural products.

Taken together, these preliminary data allow for the first side-by-side comparative analysis of a collection of communesin derivatives, including all nine naturally occurring communesins A--I ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}), suggest primarily that (a) substitution at N8′ can have a dramatic effect on potency; (b) N8-methyl derivatives exhibit improved activity relative to their N8-formyl or N8-unsubstituted counterparts; and (c) activity is nominally proportional to the size of the N1′ substituent.

Conclusions {#sec3}
===========

In summary, we have developed a *unified enantioselective total synthesis of all known epoxide-containing communesin alkaloids* ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}), including the first total synthesis of communesins C--E, and G--I, in addition to related derivatives from a single advanced synthetic intermediate (+)-**19**. Our synthesis is predicated on the convergent and modular diazene-directed assembly of two complex fragments to secure the critical C3a--C3a′ linkage followed by a guided biomimetic aminal reorganization to deliver the heptacyclic core of these alkaloids. Concise gram-scale enantioselective syntheses of the fragments were devised, with highlights including the application of a new, specifically designed sulfinamide chiral auxiliary, an efficient calcium trifluoromethanesulfonate promoted intramolecular amination, a diastereoselective epoxidation that simultaneously converts the new chiral auxiliary to a sulfonyl-based amine protective group, and the application of a silver-mediated cyclotryptamine-C3a′-sulfamate synthesis from a readily available enantioenriched C3a′-bromocyclotryptamine. The modularity of our convergent approach enabled the *stereochemical revision of (−)-communesin I* ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}), the most recently isolated communesin analogue. Furthermore, the generality of our biomimetic heterodimer reorganization was demonstrated in the synthesis of an unnatural constitutional isomer of the communesin skeleton, the *iso*-communesin^[@cit5b]^ derivative (+)-**59**. We also disclose the first side-by-side anticancer profiling of all nine naturally occurring communesin alkaloids and a selection of eight complex derivatives for cytotoxicity against five human cancer cell lines. From these data, we have identified (−)-communesin B as the most potent natural isolate and discovered that derivatives containing an N8′-SES substituent exhibit up to a 10-fold increase in potency over the natural products, with (−)-*N*8′-SES-communesins B (**45**) and G (**47**) being the most potent communesin derivatives found to date. These findings form the basis of our ongoing efforts aimed at detailed chemical and biological study of these fascinating alkaloids.
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